Jaime Merchan, MD, discusses the efficacy results observed in the LITESPARK-013 trial of belzutifan in patients with advanced clear cell renal cell carcinoma.

Neoadjuvant therapy for high-risk renal cell carcinoma (RCC) may offer a survival advantage over adjuvant therapy, according to data presented at the 2024 annual meeting of the Society of Urologic ...

Cystic renal cell carcinoma is a predominantly cystic lesion with a small solid component (25% or less). Renal cell carcinoma usually presents as a solid mass; however, in 10–22% of cases ...

Merck MRK announced that EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended granting conditional ...

Cell biology is the discipline of biological sciences that studies the structure, physiology, growth, reproduction and death of cells. Research in cell biology uses microscopic and molecular tools ...

High efficacy statins are associated with a 13% increased risk of developing severe renal failure, including those at risk for ischemic heart disease, diabetes, and CKD. More research is still ...

Cell division is the process by which a parental cell gives rise to two daughter cells. The process involves both nuclear division and cytokinesis and can either produce two equal cells (symmetric ...

The trial was designed to evaluate remestemcel-L, an allogeneic bone marrow-derived mesenchymal stromal cell (MSC) therapy, in pediatric patients who developed steroid-refractory acute GVHD after ...

Based on Angioplasty stent type, the interventional cardiology devices market has been segmented into drug-eluting stents, ...

Dec. 16, 2024 — Researchers have uncovered unexpected diversity in the genetic processes that determine the sex of the African clawed frog, a significant discovery in what was already one of the ...

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.